Comparison of patient outcomes stratified by histology among pemetrexed (P)-treated patients (pts) with stage IIIB/IV non-small cell lung cancer (NSCLC) in two phase II trials

8096 Background: Preclinical data indicated that overexpression of TS correlates with reduced sensitivity to P in antifolate- resistant cell lines. A planned subset analysis of a phase 3 trial (Sca...